from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1068c/PE_PGRS20

LFCtreatmentdescriptionclass of inhibitor

1.069

Amikacinug/mL Amikacintranslation

1.003

Cap5-10ug/mL Capreomycintranslation

1.515

Rox10-50 ug/mL Roxithromycintranslation

-0.254

SM2-5 ug/mL Streptomycintranslation

0.884

Tet5-10 ug/mL Tetracyclinetranslation

-0.140

Rif0.2-5ug/mL Rifampicintranscription

-0.885

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.143

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.812

CPZ10-50 ug/mL Chlorpromazinerespiration

0.814

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.067

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.091

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.366

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.175

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.430

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.907

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.936

KCN5-20 ug/mL Potassium cyaniderespiration

1.592

NaN30.2-2 mM Sodium aziderespiration

-1.195

Nigericin50 uM Nigericinrespiration

-0.120

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.785

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.312

menadione6-10 ug/mL Menadionerespiration

0.378

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.427

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.277

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.030

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.636

NRP_1Non-replicating persistence stage 1dosRassociated

-0.357

Amp0.2mg/mL AmpicillincellWall

-0.258

Cephalexin20-100 ug/mL CephalexincellWall

-0.224

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.258

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.194

EMB10-20 ug/mL EthambutolcellWall

-0.172

Eta12-40 ug/mL EthionamidecellWall

0.232

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.337

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.388

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.536

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.596

BZA0.12 mg/mL BenzamidearomaticAmides

0.773

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.190

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.245

H2O24 mM hydrogen peroxideDNAdamaging

-0.434

Levo10 ug/mL LevofloxacinDNAdamaging

-0.217

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.259

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.848

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.231

UVUV-irradiationDNAdamaging

-0.545

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.322

Antimycin12.5-50 ug/mL Antimycin A?

-1.741

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.509

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.541

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.186

PA8240.2-2 ug/mL PA-824?

0.805

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.026

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.660

Verapamil50 uM Verapamil?

-2.013

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.816

methoxatin10-20 ug/mL Methoxatin?